Template:NSCLC molecular workup: Difference between revisions

Jump to navigation Jump to search
Mikael Häggström (talk | contribs)
m Specified
Mikael Häggström (talk | contribs)
+Ref
 
Line 1: Line 1:
{{Edit|Template:NSCLC molecular workup}}<br>For primary lung non-small cell carcinoma (NSCLC) stages IB - IV (such as being more than 3 cm in size), generally perform full next generation sequencing panel (DNA and RNA) with PDL-1 immunostaining. For advanced stage NSCLC that are not candidates for biopsy or re-biopsy, “liquid biopsy” on peripheral blood is a viable option.
{{Edit|Template:NSCLC molecular workup}}<br>For primary lung non-small cell carcinoma (NSCLC) stages IB - IV (such as being more than 3 cm in size), generally perform full next generation sequencing panel (DNA and RNA) with PDL-1 immunostaining. For an advanced stage NSCLC that is not a candidate for biopsy or re-biopsy, a viable alternative is “liquid biopsy” on peripheral blood for circulating tumor DNA.<ref>{{cite web|url=https://www.nccn.org/professionals/physician_gls/pdf/nscl.pdf|title=National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology (NCCN Guidelines) - Non-Small Cell Lung Cancer. Version 3.2024. Section: Principles of molecular and biomarker analysis|date=2024-03-12}}</ref>